U.S. DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Application (Research Development, Diagnostics), By End Use, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service Type
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. DNA Synthesis Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. DNA synthesis Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. U.S. DNA Synthesis Market: Service Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. DNA Synthesis Market Service Type Movement Analysis
• 4.3. U.S. DNA Synthesis Market Size & Trend Analysis, by Service Type, 2021 to 2033 (USD Million)
• 4.4. Oligonucleotide synthesis
  • 4.4.1. Oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.2. By Type
    • 4.4.2.1. Standard oligonucleotides synthesis
      • 4.4.2.1.1. Standard oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2.2. Custom oligonucleotide synthesis
      • 4.4.2.2.1. Custom oligonucleotides synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.3. By Length
    • 4.4.3.1. Less than 50nt
      • 4.4.3.1.1. Less than 50nt market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3.2. 51-100nt
      • 4.4.3.2.1. 51-100nt market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3.3. 101-150nt
      • 4.4.3.3.1. 101-150nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3.4. More than 150nt
      • 4.4.3.4.1. More than 150nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Gene synthesis
  • 4.5.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5.2. By Type
    • 4.5.2.1. Custom gene synthesis
      • 4.5.2.1.1. Custom gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.2.2. Gene library synthesis
      • 4.5.2.2.1. Gene library synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5.3. By Length
    • 4.5.3.1. Less than 500nt
      • 4.5.3.1.1. Less than 500nt market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3.2. 501-1000nt
      • 4.5.3.2.1. 501-1000nt market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3.3. 1001-1500nt
      • 4.5.3.3.1. 1001-1500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3.4. 1501-2000nt
      • 4.5.3.4.1. 1501-2000nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3.5. 2001-2500nt
      • 4.5.3.5.1. 2001-2500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3.6. More than 2500nt
      • 4.5.3.6.1. More than 2500nt synthesis market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. DNA Synthesis Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. DNA Synthesis Market Application Movement Analysis
• 5.3. U.S. DNA Synthesis Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Research & Development
  • 5.4.1. Research & development market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Oligonucleotide synthesis
    • 5.4.2.1. Oligonucleotide synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.2. PCR
      • 5.4.2.2.1. PCR synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.3. NGS
      • 5.4.2.3.1. NGS synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.4. CRISPR
      • 5.4.2.4.1. CRISPR synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.5. Cloning and mutagenesis
      • 5.4.2.5.1. Cloning and mutagenesis synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.6. Others
      • 5.4.2.6.1. Others synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.3. Gene synthesis
    • 5.4.3.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3.2. Synthetic biology
      • 5.4.3.2.1. Synthetic biology tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3.3. Vaccine development
      • 5.4.3.3.1. Vaccine development synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3.4. Genetic engineering
      • 5.4.3.4.1. Genetic engineering synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3.5. Others
      • 5.4.3.5.1. Others synthesis tumors market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Diagnostics
  • 5.5.1. Diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Therapeutics
  • 5.6.1. Therapeutics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.2. RNAi therapies
    • 5.6.2.1. RNAi therapies market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.3. Antisense and oligonucleotide-based therapies
    • 5.6.3.1. Antisense and oligonucleotide-based therapies market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.4. Others
    • 5.6.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. DNA Synthesis Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. DNA Synthesis Market End Use Movement Analysis
• 6.3. U.S. DNA Synthesis Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Biopharmaceutical & Diagnostic Companies
  • 6.4.1. Biopharmaceutical & diagnostic companies market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Contract Research Organizations
  • 6.6.1. Contract Research Organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Thermo Fisher Scientific Inc.
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Service benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Twist Bioscience
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Service benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. BIONEER CORPORATION
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Service benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Eton Bioscience, Inc
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Service benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. LGC Biosearch Technologies
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Service benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. IBA Lifesciences GmbH
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Service benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Eurofins Scientific
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Service benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Integrated DNA Technologies, Inc.
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Service benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Quintara Biosciences
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Service benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. GenScript
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Service benchmarking
    • 7.4.10.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviation
• Table 2 U.S. DNA synthesis market, by service type, 2021 - 2033 (USD Million)
• Table 3 U.S. DNA synthesis market, by application, 2021 - 2033 (USD Million)
• Table 4 U.S. DNA synthesis market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 U.S. DNA synthesis market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segments snapshot
• Fig. 14 Competitive landscape snapshot
• Fig. 15 U.S. DNA synthesis market value, 2024 (USD billion)
• Fig. 16 Market trends & outlook
• Fig. 17 PESTEL analysis
• Fig. 18 Porter's five forces analysis
• Fig. 19 U.S. DNA synthesis market: Service type outlook & key takeaways
• Fig. 20 U.S. DNA synthesis market: Service type movement analysis
• Fig. 21 Oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 22 Standard oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 23 Custom oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 24 Less than 50 nt market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 25 51-100 nt market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 26 101-150 nt market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 27 More than 150 nt market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 28 Gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 29 Custom gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 30 Gene library synthesis market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 31 Less than 500 nt market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 32 501-1,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 33 501-1,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 34 1,501-2,000 nt market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 35 2,001-2,500 nt market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 36 More than 2,500 nt market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 37 U.S. DNA synthesis Market: Application outlook & key takeaways
• Fig. 38 U.S. DNA synthesis Market: Application movement analysis
• Fig. 39 Research and development market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 40 Oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 41 PCR market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 42 NGS market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 43 CRISPR market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 44 Cloning and mutagenesis market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 45 Others market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 46 Gene synthesis market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 47 Synthetic biology market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 48 Vaccine development market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 49 Genetic engineering market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 50 Others market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 51 Diagnostics market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 52 Therapeutics market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 53 RNAi therapies market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 54 Antisense oligonucleotide-based therapies market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 55 Others market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 56 U.S. DNA synthesis market: End Use outlook & key takeaways
• Fig. 57 U.S. DNA synthesis market: End Use movement analysis
• Fig. 58 Biopharmaceutical and diagnostics companies market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 59 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 60 Contract research organizations market estimates and forecasts, 2021 - 2033 (USD million)
• Fig. 61 Strategic framework